CME Group Inc. vs Morgan Stanley
Side-by-side comparison of CME and MS
CME Group Inc. (CME) trades at $298.93 and Morgan Stanley (MS) at $178.16. CME has a market cap of $113.2B, while MS stands at $264.9B. On earnings per share, CME leads at $11.16 vs $10.21 for MS. CME offers a higher dividend yield at 3.75% compared to 2.21% for MS. Use the table below to compare key financials side by side.
| Metric | CME | MS |
|---|---|---|
| Price | $298.93 | $178.16 |
| Market Cap | $113.2B | $264.9B |
| Day Change | -1.28% | +1.22% |
| Revenue | $6.5B | — |
| Net Income | $4.1B | $16.9B |
| EPS (Diluted) | $11.16 | $10.21 |
| Total Assets | $198.4B | $1.4T |
| Stockholders' Equity | $28.7B | $111.6B |
| Total Debt | — | $341.7B |
| Cash & Equivalents | $4.4B | $111.7B |
| Dividend Yield | 3.75% | 2.21% |
Frequently Asked Questions
Is CME bigger than MS?
By market capitalization, Morgan Stanley (MS) is larger at $264.9B vs $113.2B for CME Group Inc. (CME).
Which has a higher dividend yield, CME or MS?
CME Group Inc. (CME) has the higher dividend yield at 3.75%, compared to 2.21% for Morgan Stanley (MS).
Which is more profitable, CME or MS?
Based on diluted earnings per share (EPS), CME Group Inc. (CME) is more profitable at $11.16 EPS vs $10.21 for Morgan Stanley (MS).
What is the difference between CME Group Inc. and Morgan Stanley?
CME Group Inc. (CME) and Morgan Stanley (MS) are both financial sector companies listed on U.S. exchanges. This page compares them across price, market capitalization, revenue, net income, EPS, total assets, debt, and dividend yield based on the latest available data.